Merus N.V.

Ownership Transactions Reported by 18 Insiders

Symbol
MRUS on Nasdaq
Industry
Pharmaceutical Preparations
Location
Yalelaan 62, 3584 Cm Utrecht, DE

Insiders trading volume in the past year

Merus N.V. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sven Ante Lundberg President, CEO & PEO, Director $12.2M Nov 25, 2025
Bvf Partners L P/Il 10%+ Owner $6.47M Oct 7, 2021
Gregory D. Perry Chief Financial Officer & PFO $1.45M Jan 29, 2025
Hui Liu EVP, CBO & Head of Merus US $1.45M May 7, 2024
Peter Silverman Coo & Gc $1.45M -$4.59M -76% Jul 17, 2025
Andrew Joe Svp, Cmo $1.45M May 7, 2024
Harry Shuman VP Controller, PAO $1.43M -$990K -40.9% Nov 25, 2025
Lex Bakker SVP, Chief Development Officer $1.16M Jan 31, 2022
John de Kruif SVP & Chief Technology Officer $1.15M Jan 31, 2022
A. Geuijen Cecile SVP & Chief Scientific Officer $744K Jan 31, 2022
Jason Haddock Director $239K May 22, 2025
Victor Sandor Director $120K May 22, 2025
Maxine Gowen Director $120K May 22, 2025
Anand Mehra Director $120K May 22, 2025
Mark T. Iwicki Director $120K May 22, 2025
Paolo Pucci Director $120K May 22, 2025
Len Kanavy Director $120K May 22, 2025
Fabian Zohren Chief Medical Officer Jan 29, 2025

Recent Insider Transactions by Companies or Individuals for Merus N.V.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.